Protecting Innovation.Advancing Safer Prescriptions.
At Xact Laboratories, we believe pharmacogenomics should be the standard of care. That's why we've invested in technology that not only delivers insights but also protects the pathways that make safer prescribing possible.
Our Patents at a Glance
Revolutionary technology protecting the future of pharmacogenomic integration in healthcare systems
U.S. Patent No. 12,354,724 B2
Issued: July 8, 2025
Title:
Automated transmission of pharmacogenomic and genetic efficacy data into pharmacy and provider networks
Plain-English Summary:
Enables secure, real-time, and properly formatted transmission of genetic test results to pharmacies, doctors, and insurance systems for seamless integration into workflows.
U.S. Patent No. 12,217,874
Issued: February 4, 2025
Title:
System and method for suggesting insurance-eligible genetic efficacy tests
Plain-English Summary:
This technology automatically checks a patient's insurance coverage, medications, and diagnoses to suggest available pharmacogenomic tests. It then sends an order form for those tests straight into the clinician's system—making it seamless for doctors and labs.
U.S. Patent No. 11,398,312
Issued: July 26, 2022
Title:
Preventing the fill of ineffective or under-effective medications through integration of genetic efficacy testing results
Plain-English Summary:
This method integrates genetic results into pharmacy and PBM systems. If a medication is flagged as ineffective, the system treats it like an allergy and blocks the fill—preventing unsafe or useless prescriptions at checkout.
U.S. Patent No. 11,380,424
Issued: July 5, 2022
Title:
System and method for genetic-based efficacy testing
Plain-English Summary:
Similar to the prior patent, it alerts providers about prescribed treatments that won't work well based on genetic markers—integrated directly into EMRs to guide better prescribing decisions.
U.S. Patent No. 11,227,685 B2
Issued: January 11, 2022
Title:
System and method for integrating pharmacogenomic test results into prescribing platforms
Plain-English Summary:
Facilitates the incorporation of genetic testing results into electronic prescribing tools and decision support systems, improving medication selection at the point of care.
U.S. Patent No. 11,527,331
Issued: December 13, 2022
Title:
System and method for determining the effectiveness of medications using genetics
Plain-English Summary:
Flags ineffective medications based on genetic markers and alerts providers to optimize prescribing decisions.
Bottom Line
Together, these patents cover everything from identifying relevant genetic tests to alerting providers/pharmacists, to blocking ineffective meds, and ensuring secure data flow across systems. This creates a fully automated, protected, and intelligent platform for real-world pharmacogenomics at scale.
Interested in Partnering or Licensing?
We offer non-exclusive licensing opportunities to organizations looking to integrate clinical PGx workflows.
Contact our Team